Psilocybin, ein psychotroper Wirkstoff aus dem mexikanischen RauschpilzPsilocybe mexicana Heim
The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
Dennis, R. W. G., Wasson, V. P., & Wasson, R. G. (1957) · Kew Bulletin · doi:10.2307/4113701 · Cited by 122
W., G. M., Wasson, V. P., & Wasson, R. G. (1958) · Geographical Review · doi:10.2307/211720 · Cited by 65
Research works printed but not linked: 3
- R. Heim, C. R. Acad. Sci.242, 965 (1956).
- R. Heim, C. R. Acad. Sci.242, 1389 (1956);244, 695 (1957); Revue de Mycologie22, 20, 36 (1957).
- R. Heim undR. Cailleux, C. R. Acad. Sci.244, 3109 (1957);245, 597, 1761 (1957).
Cited by
Carhart-Harris, R. L., Bolstridge, M., Rucker, J., Day, C. M. J., Erritzoe, D., Kaelen, M., Bloomfield, M., Rickard, J. A., Forbes, B., Feilding, A., et al. (2016) · The Lancet Psychiatry · doi:10.1016/s2215-0366(16)30065-7 · Cited by 1,540
The Therapeutic Potential of Psychedelic Drugs: Past, Present, and Future
Carhart-Harris, R. L., & Goodwin, G. M. (2017) · Neuropsychopharmacology · doi:10.1038/npp.2017.84 · Cited by 706
Studerus, E., Kometer, M., Hasler, F., & Vollenweider, F. X. (2011) · Journal of Psychopharmacology · doi:10.1177/0269881110382466 · Cited by 532
Madsen, M. K., Fisher, P. M., Burmester, D., Dyssegaard, A., Stenbæk, D. S., Kristiansen, S., Johansen, S. S., Lehel, S., Linnet, K., Svarer, C., et al. (2019) · Neuropsychopharmacology · doi:10.1038/s41386-019-0324-9 · Cited by 517
Simple indole alkaloids and those with a nonrearranged monoterpenoid unit
Ishikura, M., Yamada, K., & Abe, T. (2010) · Natural Product Reports · doi:10.1039/c005345g · Cited by 457
Adverse effects of psychedelics: From anecdotes and misinformation to systematic science
Schlag, A. K., Aday, J., Salam, I., Neill, J. C., & Nutt, D. J. (2022) · Journal of Psychopharmacology · doi:10.1177/02698811211069100 · Cited by 325
Effects of psilocybin on hippocampal neurogenesis and extinction of trace fear conditioning
Catlow, B. J., Song, S., Paredes, D. A., Kirstein, C. L., & Sanchez-Ramos, J. (2013) · Experimental Brain Research · doi:10.1007/s00221-013-3579-0 · Cited by 266
The Therapeutic Potential of Psilocybin
Lowe, H., Toyang, N., Steele, B., Valentine, H., Grant, J., Ali, A., Ngwa, W., & Gordon, L. (2021) · Molecules · doi:10.3390/molecules26102948 · Cited by 242
Increased amygdala responses to emotional faces after psilocybin for treatment-resistant depression
Roseman, L., Demetriou, L., Wall, M. B., Nutt, D. J., & Carhart-Harris, R. L. (2018) · Neuropharmacology · doi:10.1016/j.neuropharm.2017.12.041 · Cited by 230
“Psilocybin, a classic psychedelic and non-selective serotonin 2A receptor (5-HT2AR) agonist, was discovered and marketed in the 1950s and 60s (Hofmann et al., 1958).”
Psychedelics in Psychiatry: Neuroplastic, Immunomodulatory, and Neurotransmitter Mechanisms
Inserra, A., De Gregorio, D., & Gobbi, G. (2021) · Pharmacological Reviews · doi:10.1124/pharmrev.120.000056 · Cited by 232
Metabolism of psilocybin and psilocin: clinical and forensic toxicological relevance
Dinis-Oliveira, R. J. (2017) · Drug Metabolism Reviews · doi:10.1080/03602532.2016.1278228 · Cited by 224
Psilocybin und Psilocin, zwei psychotrope Wirkstoffe aus mexikanischen Rauschpilzen
Hofmann, A., Heim, R., Brack, A., Kobel, H., Frey, A., Ott, H., Petrzilka, T., & Troxler, F. (1959) · Helvetica Chimica Acta · doi:10.1002/hlca.19590420518 · Cited by 224
Self-citationClinical applications of hallucinogens: a review
Garcia-Romeu, A., Kersgaard, B., & Addy, P. H. (2016) · Experimental and Clinical Psychopharmacology · doi:10.1037/pha0000084 · Cited by 201
“Background—Psilocybin is found in over 100 species of mushrooms (Stamets, 1996) and was first isolated in 1958 (Hofmann et al., 1958; Hofmann, 2013).”
BackgroundPsilocybin: from ancient magic to modern medicine
Nichols, D. E. (2020) · The Journal of Antibiotics · doi:10.1038/s41429-020-0311-8 · Cited by 184
Madsen, M. K., Fisher, P. M., Stenbæk, D. S., Kristiansen, S., Burmester, D., Lehel, S., Páleníček, T., Kuchař, M., Svarer, C., Ozenne, B., et al. (2020) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2020.02.001 · Cited by 183
DARK Classics in Chemical Neuroscience: Psilocybin
Geiger, H. A., Wurst, M. G., & Daniels, R. N. (2018) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.8b00186 · Cited by 141
Konstitutionsaufklärung und Synthese von Psilocybin
Hofmann, A. A., Frey, A., Ott, H., Petrzilka, T., & Troxler, F. (1958) · Cellular and Molecular Life Sciences · doi:10.1007/bf02160424 · Cited by 140
Self-citationComparison of the reactions induced by psilocybin and LSD-25 in man
Isbell, H. (1959) · Psychopharmacology · doi:10.1007/bf00408109 · Cited by 140
Cross tolerance between LSD and psilocybin
Isbell, H., Wolbach, A. B., Wikler, A., & Miner, E. J. (1961) · Psychopharmacologia · doi:10.1007/bf00407974 · Cited by 137
Hallucinogenic Mushrooms in Mexico: An Overview
Guzmán, G. (2008) · Economic Botany · doi:10.1007/s12231-008-9033-8 · Cited by 111
N-Containing Compounds of Macromycetes
Liu, J. (2005) · Chemical Reviews · doi:10.1021/cr0400818 · Cited by 120
Rucker, J., Marwood, L., Ajantaival, R.-L. J., Bird, C., Eriksson, H., Harrison, J., Lennard-Jones, M., Mistry, S. J., Saldarini, F., Stansfield, S. C., et al. (2022) · Journal of Psychopharmacology · doi:10.1177/02698811211064720 · Cited by 123
Investigation of the Structure–Activity Relationships of Psilocybin Analogues
Klein, A. K., Chatha, M., Laskowski, L. J., Anderson, E. I., Brandt, S. D., Chapman, S. J., McCorvy, J. D., & Halberstadt, A. L. (2020) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.0c00176 · Cited by 109
Van Court, R. C., Wiseman, M. S., Meyer, K. W., Ballhorn, D. J., Amses, K. R., Slot, J. C., Dentinger, B. T. M., Garibay-Orijel, R., & Uehling, J. K. (2022) · Fungal Biology · doi:10.1016/j.funbio.2022.01.003 · Cited by 94
Dose–response relationships of psilocybin-induced subjective experiences in humans
Hirschfeld, T., & Schmidt, T. T. (2021) · Journal of Psychopharmacology · doi:10.1177/0269881121992676 · Cited by 106
Clinic, H.-A. M., & Clinic, H.-A. F. M. (1967) · Medical Entomology and Zoology · Cited by 87
Baeocystin and Norbaeocystin: New Analogs of Psilocybin from Psilocybe baeocystis
Leung, A. Y., & Paul, A. G. (1968) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600571007 · Cited by 85
High dose psilocybin is associated with positive subjective effects in healthy volunteers
Nicholas, C. R. N., Henriquez, K. M., Gassman, M., Cooper, K. M., Muller, D., Hetzel, S., Brown, R., Cozzi, N. V., Thomas, C., & Hutson, P. R. (2018) · Journal of Psychopharmacology · doi:10.1177/0269881118780713 · Cited by 91
A worldwide geographical distribution of the neurotropic fungi, an analysis and discussion.
Guzmán, G., Allen, J., & Gartz, J. (2000) · Cited by 81
The Psychedelic Future of Post-Traumatic Stress Disorder Treatment
Zaretsky, T. G., Jagodnik, K. M., Barsic, R., Antonio, J. H., Bonanno, P. A., MacLeod, C., Pierce, C., Carney, H., Morrison, M. T., Saylor, C. F., et al. (2024) · Current Neuropharmacology · doi:10.2174/1570159x22666231027111147 · Cited by 102
A Biochemical Concept of Mental Disease
McIsaac, W. M. (1961) · Postgraduate Medicine · doi:10.1080/00325481.1961.11694351 · Cited by 80
Duan, W., Cao, D., Wang, S., & Cheng, J. (2023) · Chemical Reviews · doi:10.1021/acs.chemrev.3c00375 · Cited by 85
Blei, F., Dörner, S., Fricke, J., Baldeweg, F., Trottmann, F., Komor, A. J., Meyer, F., Hertweck, C., & Hoffmeister, D. (2019) · Chemistry - A European Journal · doi:10.1002/chem.201904363 · Cited by 86
Natural product-derived compounds in clinical trials and drug approvals
Butler, M. S., Capon, R. J., Blaskovich, M. A. T., & Henderson, I. R. (2025) · Natural Product Reports · doi:10.1039/d5np00031a · Cited by 97
Psilocybin-induced stimulus control in the rat
Winter, J. C., Rice, K. C., Amorosi, D. J., & Rabin, R. A. (2007) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2007.06.003 · Cited by 86
Stebelska, K. (2013) · Therapeutic Drug Monitoring · doi:10.1097/ftd.0b013e31828741a5 · Cited by 86
Abwandlungsprodukte von Psilocybin und Psilocin. 2. Mitteilung über synthetische Indolverbindungen
Troxler, F., Seemann, F., & Hofmann, A. A. (1959) · Helvetica Chimica Acta · doi:10.1002/hlca.19590420638 · Cited by 71
Self-citationCohen, S. (1971) · Birkhäuser Basel eBooks · doi:10.1007/978-3-0348-7078-8_2 · Cited by 71
Gotvaldová, K., Hájková, K., Borovička, J., Jurok, R., Cihlářová, P., & Kuchař, M. (2021) · Drug Testing and Analysis · doi:10.1002/dta.2950 · Cited by 67
Mushroom Toxins: Chemistry and Toxicology
Yin, X., Yang, A.-A., & Gao, J. (2019) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.9b00414 · Cited by 65
The emerging role of psilocybin and MDMA in the treatment of mental illness
Gill, H., Gill, B., Chen-Li, D. C. J., El‐Halabi, S., Rodrigues, N. B., Cha, D. S., Lipsitz, O., Lee, Y. L., Rosenblat, J. D., Majeed, A., et al. (2020) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2020.1826931 · Cited by 63
Smausz, R., Neill, J. C., & Gigg, J. (2022) · Journal of Psychopharmacology · doi:10.1177/02698811221092508 · Cited by 70
Injury‐Triggered Blueing Reactions of Psilocybe “Magic” Mushrooms
Lenz, C., Wick, J., Braga, D., García‐Altares, M., Lackner, G., Hertweck, C., Gressler, M., & Hoffmeister, D. (2019) · Angewandte Chemie International Edition · doi:10.1002/anie.201910175 · Cited by 58
Clinical toxicology of ‘magic mushroom’ ingestion
Peden, N. R., Macaulay, K. E. C., Bissett, A. F., Crooks, J., & Pelosi, A. J. (1981) · Postgraduate Medical Journal · doi:10.1136/pgmj.57.671.543 · Cited by 57
Dephosphorylation of psilocybin in the intact mouse
Horita, A., & Weber, L. J. (1962) · Toxicology and Applied Pharmacology · doi:10.1016/0041-008x(62)90102-3 · Cited by 56
Gathergood, N., & Scammells, P. J. (2003) · Organic Letters · doi:10.1021/ol0341039 · Cited by 56
Some new psychoactive substances: Precursor chemicals and synthesis‐driven end‐products
Collins, M. (2011) · Drug Testing and Analysis · doi:10.1002/dta.315 · Cited by 54
Extensive Collection of Psychotropic Mushrooms with Determination of Their Tryptamine Alkaloids
Gotvaldová, K., Borovička, J., Hájková, K., Cihlářová, P., Rockefeller, A., & Kuchař, M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232214068 · Cited by 53
Biosynthesis of bioactive natural products from Basidiomycota
Lin, H., Hewage, R. T., Lu, Y., & Chooi, Y. (2018) · Organic & Biomolecular Chemistry · doi:10.1039/c8ob02774a · Cited by 53
Liu, J., Yang, X.-C., Lu, H., Gu, Y., & Xu, P. (2018) · Organic Letters · doi:10.1021/acs.orglett.8b00503 · Cited by 53
Production Options for Psilocybin: Making of the Magic
Fricke, J., Lenz, C., Wick, J., Blei, F., & Hoffmeister, D. (2018) · Chemistry - A European Journal · doi:10.1002/chem.201802758 · Cited by 53
Lysergic acid diethylamide: a drug of ‘use’?
Das, S., Barnwal, P., Ramasamy, A., Sen, S., & Mondal, S. (2016) · Therapeutic Advances in Psychopharmacology · doi:10.1177/2045125316640440 · Cited by 58
Toxicology and Analysis of Psychoactive Tryptamines
Malaca, S., Faro, A. F. L., Tamborra, A., Pichini, S., Busardò, F. P., & Huestis, M. A. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21239279 · Cited by 52
Scalable Hybrid Synthetic/Biocatalytic Route to Psilocybin
Fricke, J., Kargbo, R. B., Regestein, L., Lenz, C., Peschel, G., Rosenbaum, M. A., Sherwood, A. M., & Hoffmeister, D. (2020) · Chemistry - A European Journal · doi:10.1002/chem.202000134 · Cited by 47
Chemistry and Toxicology of Major Bioactive Substances in Inocybe Mushrooms
Patočka, J., Wu, R., Nepovimová, E., Vališ, M., Wu, W., & Kuča, K. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22042218 · Cited by 59
The Problem of Psilocybin Mushroom Abuse
Peden, N. R., Pringle, S. D., & Crooks, J. (1982) · Human Toxicology · doi:10.1177/096032718200100408 · Cited by 46
Abuse of Indigenous Psilocybin Mushrooms: A New Fashion and Some Psychiatric Complications
Hyde, C. E., Glancy, G., Omerod, P., Hall, D., & Taylor, G. (1978) · The British Journal of Psychiatry · doi:10.1192/bjp.132.6.602 · Cited by 46
Khat and mushrooms associated with psychosis
Nielen, R. J., der Heijden, F. M. M. A. V., Tuinier, S., & Verhoeven, W. M. A. (2004) · The World Journal of Biological Psychiatry · doi:10.1080/15622970410029908 · Cited by 48
Hofmann, A. A., & Troxler, F. (1959) · Cellular and Molecular Life Sciences · doi:10.1007/bf02166696 · Cited by 45
Self-citationMushroom Toxins — A Brief Review of the Literature
Buck, R. W. (1961) · New England Journal of Medicine · doi:10.1056/nejm196110052651406 · Cited by 43
Psychoactive tryptamines from basidiomycetes
Wurst, M., Kysilka, R., & Flieger, M. (2002) · Folia Microbiologica · doi:10.1007/bf02818560 · Cited by 42
Molecular characteristics of biogenic monoamines and their analogs
Carlström, D., Bergin, R., & Falkenberg, G. (1973) · Quarterly Reviews of Biophysics · doi:10.1017/s0033583500001232 · Cited by 42
Occurrence and use of hallucinogenic mushrooms containing psilocybin alkaloids
Andersson, C., Gry, J., & Kristinsson, J. (2009) · TemaNord · doi:10.6027/tn2008-606 · Cited by 41
Ethnopharmacology and Taxonomy of Mexican Psychodysleptic Plants
Díaz, J. L. (1979) · Journal of Psychedelic Drugs · doi:10.1080/02791072.1979.10472094 · Cited by 42
Taking Different Roads: l‐Tryptophan as the Origin of Psilocybe Natural Products
Lenz, C., Sherwood, A., Kargbo, R., & Hoffmeister, D. (2021) · ChemPlusChem · doi:10.1002/cplu.202000581 · Cited by 40
Genetic Survey of Psilocybe Natural Products
Dörner, S., Rogge, K., Fricke, J., Schäfer, T., Wurlitzer, J. M., Gressler, M., Pham, D. N. K., Manke, D. R., Chadeayne, A. R., & Hoffmeister, D. (2022) · ChemBioChem · doi:10.1002/cbic.202200249 · Cited by 43
Psilocybin history, action and reaction: A narrative clinical review
Sharma, P., Nguyen, Q. A., Matthews, S. J., Carpenter, E., Matthews, D. B., Patten, C. A., & Hammond, C. J. (2023) · Journal of Psychopharmacology · doi:10.1177/02698811231190858 · Cited by 44
Strumila, R., Nobile, B., Korsakova, L., Lengvenytė, A., Olié, É., López‐Castromán, J., Guillaume, S., & Courtet, P. (2021) · Pharmaceuticals · doi:10.3390/ph14121213 · Cited by 48
Production of Psilocybin in Psilocybe baeocystis Saprophytic Culture
Leung, A., Smith, A. H., & Paul, A. G. (1965) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600541104 · Cited by 37
Kamata, T., Nishikawa, M., Katagi, M., & Tsuchihashi, H. (2006) · Forensic Toxicology · doi:10.1007/s11419-006-0006-2 · Cited by 36
Analysis of extracts from Psilocybe semilanceata mushrooms by high-pressure liquid chromatography
White, P. C. (1979) · Journal of Chromatography A · doi:10.1016/0021-9673(75)85080-1 · Cited by 35
Kurtz, J. S., Patel, N., Gendreau, J. L., Yang, C., Brown, N. J., Bui, N., Picton, B., Harris, M., Hatter, M. J., Beyer, R. S., et al. (2022) · Cureus · doi:10.7759/cureus.29167 · Cited by 47
Takaba, R., Ibi, D., Yoshida, K., Hosomi, E., Kawase, R., Kitagawa, H., Goto, H., Achiwa, M., Mizutani, K., Maeda, K., et al. (2023) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-023-02778-x · Cited by 39
Wulff, A. B., Nichols, C. D., & Thompson, S. M. (2023) · Neuropharmacology · doi:10.1016/j.neuropharm.2023.109504 · Cited by 41
Repke, D. B., Ferguson, W. J., & Bates, D. K. (1977) · Journal of Heterocyclic Chemistry · doi:10.1002/jhet.5570140113 · Cited by 32
Serotonergic Psychedelics in Neural Plasticity
Łukasiewicz, K., Baker, J. J., Zuo, Y., & Lu, J. (2021) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2021.748359 · Cited by 39
Baeocystin in Psilocybe semilanceata
Repke, D. B., & Leslie, D. T. (1977) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600660130 · Cited by 31
Baeocystin, a Mono-Methyl Analog of Psilocybin from Psilocybe baeocystis Saprophytic Culture
Leung, A., & Paul, A. G. (1967) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600560132 · Cited by 30
Zur Pharmakologie von Psilocybin, einem Wirkstoff ausPsilocybe mexicana Heim
Weidmann, H., Taeschler, M., & Konzett, H. (1958) · Cellular and Molecular Life Sciences · doi:10.1007/bf02159166 · Cited by 30
Impact of psilocybin on cognitive function: A systematic review
Meshkat, S., Tello-Gerez, T. J., Gholaminezhad, F., Dunkley, B. T., Reichelt, A. C., Erritzøe, D., Vermetten, E. H. G. J. M., Zhang, Y., Greenshaw, A. J., Burback, L., et al. (2024) · Psychiatry and Clinical Neurosciences · doi:10.1111/pcn.13741 · Cited by 36
Pharmacokinetics of Psilocybin: A Systematic Review
Meshkat, S., Al-Shamali, H. F., Perivolaris, A., Tullu, T., Zeifman, R. J., Zhang, Y., Burback, L., Winkler, O., Greenshaw, A. J., Husain, M. I., et al. (2025) · Pharmaceutics · doi:10.3390/pharmaceutics17040411 · Cited by 38
Metabolism and toxicological analyses of hallucinogenic tryptamine analogues being abused in Japan
Kamata, T., Katagi, M., & Tsuchihashi, H. (2010) · Forensic Toxicology · doi:10.1007/s11419-009-0087-9 · Cited by 32
Norring, S. A., & Spigarelli, M. G. (2024) · Drug Design Development and Therapy · doi:10.2147/dddt.s443177 · Cited by 33
Alberti, F., Kaleem, S., & Weaver, J. A. (2020) · Biology Open · doi:10.1242/bio.056010 · Cited by 29
S‐Adenosyl‐ l ‐Methionine Salvage Impacts Psilocybin Formation in “Magic” Mushrooms
Demmler, R., Fricke, J., Dörner, S., Gressler, M., & Hoffmeister, D. (2019) · ChemBioChem · doi:10.1002/cbic.201900649 · Cited by 27
Synthetic approaches to camptothecin
Shamma, M., & Novák, L. (1969) · Tetrahedron · doi:10.1016/s0040-4020(01)82777-0 · Cited by 27
Ogasawara, K., & Sakagami, H. (1999) · Heterocycles · doi:10.3987/com-99-8492 · Cited by 27
A view of progress in the chemistry of indole alkaloids
Schlittler, E., & Taylor, W. I. (1960) · Cellular and Molecular Life Sciences · doi:10.1007/bf02157662 · Cited by 27
Thomson, B. (1980) · Journal of Forensic Sciences · doi:10.1520/jfs11292j · Cited by 26
Szpręgiel, I., & Bysiek, A. (2024) · Pharmacological Reports · doi:10.1007/s43440-024-00660-y · Cited by 32
The phosphate ester group in secondary metabolites.
Della-Felice, F., Bartolomeu, A. D. A., & Pilli, R. (2022) · Natural product reports (Print) · doi:10.1039/d1np00078k · Cited by 11
Botanical and Chemical Characterisation of a Forensic Mushroom Specimen of the Genus Psilocybe
Heim, R., GENEST, K., Hughes, D. W., & Belec, G. (1966) · Journal of the Forensic Science Society · doi:10.1016/s0015-7368(66)70336-3 · Cited by 25
Self-citationThe Synthesis of Indole Alkaloids
KUTNEY, J. P. (1977) · Total synthesis of natural products · doi:10.1002/9780470129661.ch2 · Cited by 25
Kamata, T., Nishikawa, M., Katagi, M., & Tsuchihashi, H. (2005) · Journal of Forensic Sciences · doi:10.1520/jfs2004276 · Cited by 24
Pharmacologic Studies on the Structure-Activity Relationship of Hydroxyindole Alkylamines
Cerletti, A., Taeschler, M., & WEIDMANN, H. (1968) · Advances in pharmacology · doi:10.1016/s1054-3589(08)60322-1 · Cited by 24
Psilocybin, an Effective Treatment for Major Depressive Disorder in Adults - A Systematic Review
Watford, T., & Masood, N. (2024) · Clinical Psychopharmacology and Neuroscience · doi:10.9758/cpn.23.1120 · Cited by 23
Lee, S., Yu, J. S., Lee, S. R., & Kim, K. H. (2021) · Natural Product Reports · doi:10.1039/d1np00049g · Cited by 24
Injury‐Triggered Blueing Reactions of Psilocybe “Magic” Mushrooms
Lenz, C., Wick, J., Braga, D., García‐Altares, M., Lackner, G., Hertweck, C., Gressler, M., & Hoffmeister, D. (2020) · Angewandte Chemie · doi:10.1002/ange.201910175 · Cited by 23
Ethnomedical, Botanical and Phytochemical Aspects of Natural Hallucinogens
Schultes, R. E., & Farnsworth, N. R. (1980) · Botanical Museum leaflets, Harvard University · doi:10.5962/p.168645 · Cited by 23
Magic truffles or Philosopher's stones: a legal way to sell psilocybin?
Pellegrini, M., Rotolo, M. C., Marchei, E., Pacifici, R., Saggio, F., & Pichini, S. (2012) · Drug Testing and Analysis · doi:10.1002/dta.1400 · Cited by 25
Metadata
- Authors
- Hofmann, A., Heim, R., Brack, A., & Kobel, H.
- Affiliations
- Muséum national d'Histoire naturelle (FR)
- Venue
- Experientia
- Published
- 1958-03
- Volume
- 14
- Issue
- 3
- Pages
- 107-109
- ISSN
- 1420-682X (ISSN-L)
- 0014-4754
- 1420-9071
- OpenAlex
- W2398867243
- Cited by
- 282
- References
- 2
- Citations by year
- 2026: 9 · 2025: 27 · 2024: 31 · 2023: 23 · 2022: 22 · 2021: 11 · 2020: 14 · 2019: 9 · 2018: 7 · 2017: 6 · 2016: 8 · 2015: 1 · 2014: 1 · 2013: 4 · 2012: 2
- FWCI
- 31.17
- Type
- journal article
- Language
- de
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Cellular and Molecular Life Sciences (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Social Sciences › Psychology › Clinical Psychology › Psychedelics and Drug Studies
- Life Sciences › Immunology and Microbiology › Applied Microbiology and Biotechnology › Microbial Natural Products and Biosynthesis
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Alkaloids: synthesis and pharmacology
- Keywords
- psilocybin, psilocin, Psilocybe mexicana, hallucinogens, psychotropic drugs, indole alkaloids, phosphorus compounds, natural product isolation
- MeSH terms
- Agaricales, Hallucinations, Indoles, Psilocybin, Psychotropic Drugs, Vegetables
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.